The United Bio-technology (hengqin) Co., Ltd.

This study tested an injection called UBT251 in 205 overweight or obese adults to see if it helps with weight loss. Participants received either the drug or a placebo for 24 weeks. The main goal was to measure how much body weight changed from the start of the study.

This study tested a new injectable medicine called UBT251 in 211 adults with type 2 diabetes who were already taking metformin. The goal was to see if it improves blood sugar control over 24 weeks and to find the best dose for future larger studies. Participants received either U…